Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Evan Miller

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
FDA, FDA and healthcare matters, FDA and healthcare regulatory
Office
Washington, D.C.
Active in the record
2024 to 2026

Deal experience

Deal types
Capital Markets & IPOM&AVenture Capital & Growth
Sectors
Consumer & RetailHealthcare & Life Sciences
Jurisdictions
ChinaGermanyNasdaqTexasUnited KingdomUnited States

Recent deals

17 announced deals in the record
Latham & Watkins Advises CordenPharma on Acquisition of AmbioPharm 4 Aug 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP life sciences and regulatory
Latham & Watkins Advises Tempus AI on US$1.5 Billion Acquisition of Personalis 21 Jul 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 1.50bn FDA regulatory
Latham & Watkins Advises MeiraGTx on US$400 Million Strategic Investment by Oberland Capital 9 Jul 2026
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP USD 400m healthcare regulatory
Latham Advises on Kardigan’s US$460 Million IPO 30 Jun 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 460m FDA and healthcare matters
Latham & Watkins Advises Boundless Bio on Merger With Serapha Bio 24 Jun 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 230m FDA and healthcare regulatory
Latham & Watkins Advises on Allogene Therapeutics’ US$200.4 Million Public Offering of Common Stock 20 Apr 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 200m FDA matters
Latham Advises on Satellos’ US$50 Million Initial US Offering 10 Feb 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 50m FDA regulatory Washington, D.C.
Latham & Watkins Advises on Alumis’ Upsized US$345 Million Public Offering of Common Stock 13 Jan 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 345m FDA matters
Latham & Watkins Represents Vera Therapeutics in US$300 Million Offering of Common Stock 16 Dec 2025
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 300m FDA matters
Latham & Watkins Advises 4D Molecular Therapeutics on US$100 Million Offering of Common Stock and Pre-Funded Warrants 8 Nov 2025
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 100m regulatory
Free account

6 more recent deals

Create a free account to see every deal team member, full deal lists on firm and lawyer pages, and to claim your profile.

REGISTER FREE SIGN IN
Deal alerts PRO

Get an email when Evan Miller is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Free account

Register free to unlock

  • Every lawyer on every deal team, not just the first three
  • The full recent-deal list on lawyer pages
  • Claim and edit your own firm or lawyer profile
  • Submit deals and corrections
  • Request a Pro trial for your team
REGISTER FREE Sign in

You have a free account. Everything in this column is open to you.

Pro

Get Pro to see all 17 deals for Evan Miller

  • Complete deal history with keyword, type, sector and year filters
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • Market share and deals by year, sector and deal type
  • Deal alerts by firm, lawyer, sector, deal type or jurisdiction
  • CSV and Excel export, up to 1,000 rows a day, and custom reports
GET PRO How Pro works
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction